The team has secured support from GenScript-ProBio as a co-developer to advance its vaccine-candidate into the clinical stage. GenScript-ProBio will contribute international experience from related projects and utilize its network to facilitate pre-clinical development and to enable fast entry into clinical studies. Within the frame of a strategic partnership, GenScript-ProBio
CollaborationSAGEbio secures collaboration with leading GMP developer
March 11, 2022